SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-24-000164
Filing Date
2024-01-09
Accepted
2024-01-09 17:30:24
Documents
12
Period of Report
2024-01-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_010924.htm   iXBRL 8-K 27704
  Complete submission text file 0001171843-24-000164.txt   204615

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cmpx-20240108.xsd EX-101.SCH 3030
3 XBRL LABEL FILE cmpx-20240108_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE cmpx-20240108_pre.xml EX-101.PRE 22369
6 EXTRACTED XBRL INSTANCE DOCUMENT f8k_010924_htm.xml XML 3412
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 617-500-8099
Compass Therapeutics, Inc. (Filer) CIK: 0001738021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39696 | Film No.: 24524229
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)